US Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers

March 2013 | 1037 pages | ID: UEAA3770F0AEN
Venture Planning Group

Abstracts

This report presents a comprehensive analysis of the US infectious disease testing market, including:

• Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
• Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in US hospitals, blood banks, physician offices, public health and commercial laboratories.
• Instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.

Contains 1,037 pages and 177 tables

Contents

INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

  A. MAJOR INFECTIOUS DISEASE TESTS

1. AIDS
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
2. Adenovirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  d. Adeno-Associated Viruses(AAV)
3. Aeromonas
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
5. Arboviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
6. Babesiosis
  a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
8. Blastocystis Hominis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
9. Brucella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
10. Campylobacter
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
11. Candida
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
12. Chagas Disease
  a. Background
13. Chancroid
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
14. Chlamydia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
15. Clostridium Difficile
  a. Background
  b. Diagnostic Tests
  c. Drugs and Vaccines
16. Coronaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
17. Coxsackieviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
  a. Background
  b. Diagnostic Tests
  c. Vaccines